Investor Resources
Frequently Asked Questions
What does Altanine do?
Altanine is a specialty pharmaceutical company focused on enhancing drug delivery systems. Utilizing proprietary enteric coating and microencapsulation technologies, the company aims to improve the bioavailability of medications, reduce side effects, and enhance patient comfort.
What differentiates Altanine's technology?
The company’s proprietary enteric coating technology allows for targeted drug release in the intestine, bypassing stomach degradation. This approach enhances drug stability, improves absorption, and potentially reduces gastrointestinal side effects.
How do I contact Altanine Investor Relations?
For all investor-related inquiries, please contact:
Investor Relations Contact
Email: investors@altanine.com
Phone: +1 (213) 521-4780
Who is Altanine's transfer agent and how do I contact them?
Altanine’s transfer agent is Continental Stock Transfer & Trust Company.
They can be reached via email at: cstmail@continentalstock.com.
What year was the company founded?
Altanine was founded in 2023.
Where is Altanine headquartered?
Altanine’s corporate headquarters is located at: 10940 Wilshire Blvd., Suite 705, Los Angeles, California 90024.
What is Altanine's fiscal year end?
Altanine’s fiscal year ends on December 31.
Who is Altanine's outside legal counsel?
Altanine is represented by Greenberg Traurig, LLP, which serves as the company’s external legal advisors.
Who is Altanine's independent auditor?
Altanine’s independent auditor is Rose Snyder & Jacobs LLP.
Thank You!
Your request has been received!
We will reach out to you shortly.
